Conference abstractPublished 16 Oct 2017
Economic burden of the treatment to psoriatic patients in the polish national health fund population: Prevalence, health care utilization patterns and costs
University of Tampere, Finland; University of Osnabrueck, Germany
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Psoriasis is a chronic, noncommunicable disease, affecting individuals all over the world, with no predilection for sex. There is a need for good quality epidemiological and economic data to better understand the dimension of the problem and plan health care expenditure. The Polish National Health Fund (PNHF) is a universal, multi-payer statutory health care system, covering most citizens. The purpose of this study is to describe and assess prevalence of psoriasis in Poland, the health care utilization pattern and costs for this group. The cohort consisted of 190,258 patients who had 1 or more claims for psoriasis (ICD-10 code L40) during the study period (January 2015 - December 2015) and was obtained from the database of the PNHF. In 2015, the database covered 33,594,006 individuals (87.4% of Polish citizens). The national prevalence of psoriasis was 0.57%. The main component of the total 1-year cost of health care services paid by PNHF was inpatient cost $3,004,626. The outpatient cost was $6,103,907. The above-mentioned expenditures made up 0.07% and 0.21% of the total 1-year PNHF expenditure for inpatient and outpatient services, respectively. The mean hospital stay per hospitalized patient per year was 10.86 days. The costs of sickness benefit paid both by the Polish Social Insurance Institution and employers was $3,014,621. The mean duration of the sick leave was 13.32 days. This is the first study in Europe to assess the prevalence of psoriasis in such a big cohort. The prevalence of psoriasis among Polish patients is considerably low in contrast to other European studies. Nevertheless, the economic burden of psoriasis is significant in Poland. Further research is needed to assess the influence of the health care utilization pattern and legitimacy of health care expenditures on patient outcomes.
Subjects
DermatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical & Experimental Dermatology Research
- SubjectDermatology
- BylineArticles whose byline prints “Irmina Maria Michalek”
- BylineArticles whose byline prints “Swen Malte John”
